At a glance
- Originator Nonindustrial source
- Class Antidementias; Neuroprotectants
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 25 Aug 1998 No-Development-Reported for Alzheimer's disease in Japan (Unknown route)
- 11 Mar 1996 New profile
- 11 Mar 1996 Preclinical development for Alzheimer's disease in Japan (Unknown route)